• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Hambrecht & Quist Capital Management

edit

Hambrecht & Quist Capital Management, LLC (“HQCM”), a registered investment adviser based in Boston, Massachusetts, is currently the investment adviser for two closed-end equity funds, H&Q Healthcare Investors and H&Q Life Sciences Investors. The Funds invest in growth equities, both public and private, in the healthcare and life sciences industries.

Recent Milestones

edit

• 
  Hambrecht & Quist Capital Management invested in Veniti. (3/7/11)
  Posted 3/7/11 at 8:46pm via bizjournals.com
• 
  Hambrecht & Quist Capital Management invested in Tibion Bionic Technologies. (3/1/11)
  Posted 3/1/11 at 7:14pm via earthtimes.org
• 
  Hambrecht & Quist Capital Management invested in Euthymics Bioscience. (7/22/10)
  Posted 7/23/10 at 6:33pm via euthymics.com
• 
  Hambrecht & Quist Capital Management invested in FlowCardia. (8/30/07)
  Posted 7/16/09 at 5:25am via flowcardia.com
• 
  Hambrecht & Quist Capital Management invested in Raven Biotechnologies. (10/12/05)
  Posted 7/1/10 at 3:44am via freshnews.com

Investments

Videos

Sources

1. Veniti raises $13.5M, plans to buy Varix, Teneo (bizjournals.com) [edit]
2. Tibion Corporation Announces New $10 Million Financing Round, New Board Chairman & Board Members (earthtimes.org) [edit]
3. EUTHYMICS BIOSCIENCE, INC. CLOSES $24 MILLION SERIES A FINANCING AND COMPLETES ACQUISITION OF DOV PHARMACEUTICAL (euthymics.com) [edit]
4. FlowCardia, Inc. Raises $30 Million In Series C Financing (flowcardia.com) [edit]
5. RAVEN BIOTECHNOLOGIES INC. RAISES $48.3 MILLION IN SERIES D FINANCING (freshnews.com) [edit]